New long COVID index highlights five symptom subtypes

Researchers provide a detailed report of the updated 2024 long COVID research index.

FDA Expands Use of RSV Vaccine to Include More Adults

The FDA expanded the approval of GSK’s respiratory syncytial virus (RSV) vaccine (Arexvy) to include adults ages 50 to 59 at risk of RSV-related lower

June 11, 2024

FDA authorizes record number of new devices in 2023

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The Food and Drug Administration

January 18, 2024

U.S. cardiovascular disease costs set to skyrocket by 2050, new study reveals

New research forecasts that the economic burden of cardiovascular disease and stroke in the U.S. will nearly quadruple by 2050, highlighting the urgent need for

June 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.